IP Library Granted Patent US 11,359,239
Granted Patent B2
US 11,359,239 · App. 17/314,526 · Granted Jun 14, 2022

Methods and systems for processing polynucleotides

Inventors: Benjamin Hindson (Pleasanton, CA); Kevin Ness (Pleasanton, CA); Serge Saxonov (Oakland, CA); Paul Hardenbol (San Francisco, CA)
Assignee: 10X GENOMICS, INC.
C12Q1/6874C12Q1/6806C12Q1/6855C12Q1/6869
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,359,239
App. No.
17/314,526
Granted
Jun 14, 2022
Kind
B2
Abstract

The present disclosure provides compositions, methods, systems, and devices for polynucleotide processing. Such polynucleotide processing may be useful for a variety of applications, including polynucleotide sequencing.

Claims (60)

1. A method for cellular processing, comprising: providing an array comprising (1) a plurality of supports, (2) a plurality of cells, and (3) a plurality of barcode molecules, wherein said array comprises 1,000 microwells, wherein said plurality of barcode molecules comprises a plurality of barcode sequences that are different across said 1,000 microwells, and

wherein a microwell of said 1,000 microwells comprises: (i) a cell of said plurality of cells; and (ii) a support of said plurality of supports, wherein said support comprises a common barcode sequence that is common to said support.

2. The method of claim 1 , wherein said plurality of barcode molecules is attached to said plurality of supports.

3. The method of claim 2 , wherein said support in (ii) is attached to a barcode molecule of said plurality of barcode molecules and wherein said barcode molecule comprises a barcode sequence that is different from barcode sequences of other barcode molecules attached to other supports in microwells of said 1,000 microwells.

4. The method of claim 1 , further comprising using barcode molecules of said plurality of barcode molecules to barcode a plurality of nucleic acid molecules to thereby generate a plurality of barcoded nucleic acid molecules, wherein said plurality of cells comprises said plurality of nucleic acid molecules.

5. The method of claim 4 , further comprising using a sequencer to identify sequences of said plurality of nucleic acid molecules or derivatives thereof.

6. The method of claim 4 , wherein said barcode molecules comprise a sequence that is complementary to a sequence of a nucleic acid molecule of said plurality of nucleic acid molecules.

7. The method of claim 4 , wherein said plurality of nucleic acid molecules comprises nucleic acid molecules with overlapping sequences.

8. The method of claim 4 , wherein said plurality of nucleic acid molecules does not include a barcode sequence, and wherein a nucleic acid molecule of said plurality of nucleic acid molecules is hybridized to a barcode molecule of said plurality of barcode molecules.

9. The method of claim 4 , wherein said support is not attached to an amplification product of said plurality of nucleic acid molecules.

10. The method of claim 4 , wherein said plurality of nucleic acid molecules comprises deoxyribonucleic acid (DNA).

11. The method of claim 4 , wherein said plurality of nucleic acid molecules comprises ribonucleic acid (RNA).

12. The method of claim 4 , wherein said plurality of barcoded nucleic acid molecules comprises a plurality of double-stranded barcoded nucleic acid molecules, and wherein said method further comprises denaturing a double-stranded barcoded nucleic acid molecule of said plurality of double-stranded barcoded nucleic acid molecules to yield a single-stranded barcoded nucleic acid molecule.

13. The method of claim 12 , further comprising providing a primer molecule comprising a primer sequence that is complementary to a sequence of said single-stranded barcoded nucleic acid molecule, annealing said primer sequence to said sequence, and extending said primer molecule using said single-stranded barcoded nucleic acid molecule.

14. The method of claim 1 , wherein said plurality of supports is a plurality of beads.

15. The method of claim 14 , wherein said plurality of beads is a plurality of gel beads.

16. The method of claim 1 , wherein said microwell further comprises a reducing agent.

17. The method of claim 1 , wherein said microwell further comprises an antibody.

18. The method of claim 1 , wherein said array comprises 5,000 microwells.

19. The method of claim 1 , wherein said 1,000 microwells are a subset of microwells of said array.

20. The method of claim 1 , wherein at least one microwell of said 1,000 microwells does not include (i) a barcode molecule of said plurality of barcode molecules or (ii) any cell of said plurality of cells.

21. The method of claim 1 , wherein said providing comprises partitioning said plurality of cells into said array.

22. The method of claim 1 , wherein said microwell comprises multiple barcode molecules of said plurality of barcode molecules.

23. The method of claim 22 , wherein a barcode molecule of said multiple barcode molecules comprises a barcode sequence of said plurality of barcode sequences.

24. The method of claim 22 , wherein each of said multiple barcode molecules comprises said common barcode sequence.

25. The method of claim 1 , wherein said array comprises 2,500 microwells.

26. The method of claim 1 , wherein said array comprises 5,000 microwells.

27. The method of claim 1 , wherein said array comprises 7,500 microwells.

28. The method of claim 1 , wherein said array comprises 10,000 microwells.

29. The method of claim 1 , wherein said microwell further comprises an enzyme.

30. The method of claim 29 , wherein said enzyme is a polymerase.

31. The method of claim 1 , wherein said microwell is sealed with a sealing fluid.

32. The method of claim 31 , wherein said sealing fluid is a non-aqueous fluid.

33. The method of claim 32 , wherein said non-aqueous fluid is oil.

34. The method of claim 1 , wherein said microwell is sealed.

35. The method of claim 34 , wherein said microwell is sealed using a laminate, tape, plastic cover, or wax.

36. The method of claim 17 , wherein said antibody is coupled to an oligonucleotide reporter molecule.

37. The method of claim 36 , wherein said oligonucleotide reporter molecule comprises a reporter barcode sequence, which reporter barcode sequence identifies said antibody.

38. The method of claim 14 , wherein said plurality of beads is a plurality of degradable beads.

39. The method of claim 1 , wherein said plurality of supports comprises a plurality of solid particles.

40. The method of claim 1 , wherein said microwell comprises a reducing agent.

41. The method of claim 1 , wherein at least one microwell of said 1,000 microwells does not include a barcode molecule of the plurality of barcode molecules or any cell of said plurality of cells.

42. The method of claim 1 , wherein said cell comprises a plurality of nucleic acid molecules, and wherein a barcode molecule of said barcode molecules comprises a sequence that is complementary to a sequence of a nucleic acid molecule of said plurality of nucleic acid molecules.

43. The method of claim 1 , wherein barcode molecules of said plurality of barcode molecules comprise a priming sequence.

44. The method of claim 43 , wherein said priming sequence is an RNA priming sequence.

45. The method of claim 44 , wherein said RNA priming sequence is a poly-T sequence.

46. The method of claim 1 , wherein barcode molecules of said plurality of barcode molecules further comprise a unique molecular sequence segment.

47. The method of claim 1 , wherein barcode molecules of said plurality of barcode molecules further comprise one or more functional sequences.

48. The method of claim 47 , wherein said one or more functional sequences comprise a sequencing primer sequence or a sequencing primer binding sequence.

49. The method of claim 48 , wherein said sequencing primer sequence or said sequencing primer binding sequence is a R1 sequence, a R2 sequence, a partial R1 sequence, or a partial R2 sequence.

50. The method of claim 47 , wherein said one or more functional sequences comprise a sequence configured to attach to a flow cell of a sequencer.

51. The method of claim 50 , wherein said sequence configured to attach to said flow cell of a sequencer is a P5 sequence, a P7 sequence, a partial P5 sequence, or a partial P7 sequence.

52. The method of claim 1 , wherein said microwell comprises an endonuclease.

53. The method of claim 1 , wherein said microwell comprises a polymerase.

54. The method of claim 1 , wherein said microwell comprises a reverse transcriptase.

55. The method of claim 1 , wherein said microwell comprises an enzyme with terminal transferase activity.

56. The method of claim 1 , wherein said microwell comprises a switch oligonucleotide.

57. The method of claim 1 , wherein barcode molecules of said plurality of barcode molecules comprise a random sequence.

58. The method of claim 1 , further comprising, performing a nucleic acid reaction in said microwell.

59. The method of claim 58 , wherein said nucleic acid reaction is a nucleic acid extension reaction.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 18, 2021
From: HINDSON, BENJAMIN; HINDSON, CHRISTOPHER; SCHNALL-LEVIN, MICHAEL; NESS, KEVIN; JAROSZ, MIRNA; SAXONOV, SERGE; HARDENBOL, PAUL; BHARADWAJ, RAJIV; ZHENG, XINYING; BELGRADER, PHILLIP
To: 10X GENOMICS, INC.
Reel/Frame 057820/0639 →
Continuity (39)
Continuation 16998425 · Aug 20, 2020
Continuation 16435417 · Jun 7, 2019
Continuation 16294769 · Mar 6, 2019
Continuation 16231185 · Dec 21, 2018
Continuation 16212441 · Dec 6, 2018
Continuation 16052431 · Aug 1, 2018
Continuation In Part 16000803 · Jun 5, 2018
Continuation 15850241 · Dec 21, 2017
Continuation 15588519 · May 5, 2017
Continuation 15376582 · Dec 12, 2016
Continuation In Part 14104650 · Dec 12, 2013
Continuation In Part 14250701 · Apr 11, 2014
Continuation 14175973 · Feb 7, 2014
Continuation In Part 15598898 · May 18, 2017
Continuation 14624468 · Feb 17, 2015
Division 13966150 · Aug 13, 2013
Continuation In Part 15847752 · Dec 19, 2017
Continuation 15717871 · Sep 27, 2017
Continuation In Part 14752641 · Jun 26, 2015
Continuation In Part 16052486 · Aug 1, 2018
Continuation In Part 16000803 · Jun 5, 2018
Continuation In Part 14316447 · Jun 26, 2014
Continuation In Part 13966150 · Aug 13, 2013
Continuation In Part PCTUS2013054797 · Aug 13, 2013
Provisional Application 61844804 · Jul 10, 2013
Provisional Application 61840403 · Jun 27, 2013
Provisional Application 61800223 · Mar 15, 2013
Provisional Application 61762435 · Feb 8, 2013
Provisional Application 61683192 · Aug 14, 2012
Provisional Application 61737374 · Dec 14, 2012
Provisional Application 61762435 · Feb 8, 2013
Provisional Application 62061567 · Oct 8, 2014
Provisional Application 62017558 · Jun 26, 2014
Provisional Application 61896060 · Oct 26, 2013
Provisional Application 61909974 · Nov 27, 2013
Provisional Application 61991018 · May 9, 2014
Provisional Application 61940318 · Feb 14, 2014
Provisional Application 61937344 · Feb 7, 2014
Related Publication 20210277465A1 · Sep 9, 2021
Cited By (1)
US 12,312,640